Rasmus Stenholt
Novo Nordisk
Date: Wednesday 6 April 2016
Time: 12.45 – 14.00
Place: Rendsburggade 14, Room 3.429 (broadcast via VC to Acm15 C1/2.1.005 in Copenhagen and B108 in Esbjerg)
Abstract
The research and development process happening in the pharmaceutical industry are both similar to and very different from the same processes in the world of academia. Based on my experiences so far from working in a very large development organization, in Novo Nordisk, I will try to give some perspectives on how research and development is handled on an industrial scale, in an extremely heavily regulated area of business: development of compounds and devices for treatment of various diseases. I will also try to provide an impression of the roles that statisticians and programmers play in this process.
Bio
Rasmus Stenholt is a lead statistical programmer at Novo Nordisk, the world’s leading producer of diabetes treatments. In this job, he works primarily on data analyses based on results of clinical trials to produce new obesity treatments. Before joining Novo Nordisk, he worked for more than 10 years at Aalborg University within the areas of computer graphics and virtual reality. He holds a master of science and a Ph.D. degree, also from Aalborg University.